INS and cardiovascular disorder: While elevated glucose levels are a sign of reduced insulin secretion or action and also a proxy of type 2 diabetes (Tirosh et al., 2005; Nichols et al., 2008) and cardiovascular disease (Sarwar et al., 2010) lower levels of fasting glucose are associated with all-cause mortality (Bragg et al., 2016).